Publications found:
33,058
Sort by:
Indonesia Pharmaceuticals Industry Report - H2, 2012
US$ 475.00
... Farma Tbk, PT Merck Tbk, and PT Kimia Farma Tbk. Key Points: Indonesia’s pharmaceutical market is projected to grow at a CAGR of 10.8% over the next five ... reaching USD 12.2bn by 2017, and will rank as the sixth largest pharmaceutical market in the Asia-Pacific region. According to industry estimates, drug ...
January 2013
30 pages
The U.S. Market for Rx to OTC Switches, 6th Edition
US$ 3,995.00
... product areas contribute to the growth and development of the OTC market; however, new product development and additional regulatory review and ... label manufacturers. Competition will likely continue to be moderate in the OTC market, especially with the patent expiration of key products nearing. Consolidation ...
January 2013
290 pages
China Insulin Industry Report, 2012-2015
US$ 1,800.00
... analog market in 2011. In April 2012, the insulin phase Ⅲ project of the company held the groundbreaking ceremony. Once the project is put ... . The report highlights the followings: Global insulin industry: development, supply & demand, product R&D, competition pattern, development trend, etc. China insulin ...
January 2013
70 pages
Parkinson's Disease: World Drug Market 2013-2023
US$ 2,400.00
... Pain treatment Nicotinic receptor targeting. Also, our work covers the disease modification field, including: Possible neuroprotectants (including Azilect) Biomarkers GDNF ... for those CNS treatments. Eight main ways Parkinson's Disease: World Drug Market 2013-2023 helps you In particular, then, our ...
January 2013
161 pages
Big Data in Pharma Marketing
US$ 595.00
... on big data and how to work with it. Key Report Features A background to big data A summary of big data sources for pharma and biotech Uses for big data in pharma and biotech marketing Lessons from other industries Challenges facing those wanting to use big data ...
December 2012
76 pages
Global Pharmaceutical & Biotechnology Outlook 2013: Global Pharma
US$ 2,500.00
... Value added innovation) versus regulatory pressures to contain costs. Global Biopharmaceutical Outlook 2013-Large Cap Pharma, released by MP Advisors provides ... Emerging Markets and their importance in Growth of Large Cap Pharma 6. Global Pharma -Drugs Losing Patent Protection By 2017 7. Impact of patent ...
December 2012
131 pages
2013 Drugs of Abuse Testing Market: US, Europe, Japan
US$ 6,000.00
... from Venture Planning Group contains 311 pages and 61 tables. 'Drugs of Abuse Testing Market: US, Europe, Japan' is a unique study designed to help current ... start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace ...
December 2012
311 pages
Research Report on China's Antidepressant Market, 2013-2017
US$ 2,800.00
... , with the increasing recognition rate of doctors for depression and people's changes in treatment concepts, it is expected that the future potential of China's antidepressant market is fairly great. It is predicted that in coming years, the annual growth rate of market size of China's antidepressants in ...
December 2012
50 pages
Research Report on China's Antifungal Drug Market, 2013-2017
US$ 2,800.00
... of fungi increasingly enhances, so it indicates a sharply rising trend for the clinical application of antifungal drugs. It is expected that in coming years, the annual growth rate of market size of China's antifungal drugs will be over 20%. As for manufacturers, there are many opportunities. ...
December 2012
50 pages
Research Report on China's Diabetes Drug Market, 2013-2017
US$ 2,800.00
... aged above 20 has reached over 9.7%, and the morbidity rate of pre-diabetes (impaired fasting glucose and impaired glucose tolerance) has reached ... the market positions of insulin preparations and Acarbose. The market size of China's diabetes drugs is expected to maintain an annual growth rate of over 18% from ...
December 2012
50 pages
2013 U.S. Pharmacies & Drug Stores Industry-Product & Retail
US$ 199.00
The 2013 U.S. Pharmacies & Drug Stores Industry-Product & Retail report features 2013 current and 2014 forecast estimates on the sales of 61 product lines. The report also includes industry definition, 5-year historical trends on product lines sales. Product lines include ...
December 2012
123 pages
Research Report on China's Antithrombotic Drug Market, 2013-2017
US$ 2,400.00
... , the morbidity and mortality rates of cardiac-cerebral thrombotic diseases in China are higher than that in some developed countries. In addition, patients ... aggregation drugs and thrombolytic drugs. The overall market size of China's antithrombotic drugs is small, but it rapidly grows in recent years. The ...
December 2012
40 pages
Competitor Analysis: Herpes Virus Vaccines and Therapeutics
US$ 396.00
... infect humans. HSV-1 and HSV-2 cause the viral disease herpes simplex which can be categorized into one of several distinct disorders ... . In addition, the report lists company-specific R&D pipelines of Herpes Virus Vaccines & Therapeutics. Competitor projects are listed in a tabular format providing information ...
December 2012
56 pages
Indian Vaccine Industry: Trends & Opportunities (2012-2017)
US$ 800.00
... Indian Vaccine Industry: Trends and Opportunities (2012-2017) offers in-depth study of the global as well as the Indian vaccine industry with detailed discussion on the major segments of the vaccine industry ...
November 2012
62 pages
Drug Discovery Outsourcing: World Market 2013-2023
US$ 2,400.00
... prospects in leading regions and countries? Developments worldwide will influence the market, especially rising demand in emerging countries - China, India and others. ... shows you the commercial possibilities. Seven ways Drug Discovery Outsourcing: World Market 2013-2023 helps you In particular, then, our ...
November 2012
157 pages
Research Report on China's Hypolipidemic Drug Market, 2012-2013
US$ 2,400.00
... , the overall morbidity rate of dyslipidemia groups aged 18 and above is over 20% in China, and total patients are over 200 million nationwide. Blood ... , thus occupying a most advantageous position clinically. The overall performance of China's hypolipidemic drugs in the drug market is better than that of the ...
November 2012
55 pages
Generic Drugs: World Market 2013-2023
US$ 2,400.00
... 2012 onwards: US, European and Japanese regulations Authorised, branded and other generics, including modified products Patent expiries and business strategies, including ... . You see how revenues can increase. Nine ways Generic Drugs: World Market 2013-2023 benefits you To sum up, our report gives you ...
November 2012
149 pages
World Pharmaceutical Contract Sales Market 2013-2023
US$ 2,401.00
... for service providers and clients. Eight ways World Pharmaceutical Contract Sales Market 2013-2023 benefits you To sum up, our report ... Opinions on the sector - discover views, including a research interview Coverage of market access and rising power of healthcare payers Investigation of competition and ...
November 2012
160 pages
Macular Degeneration (AMD) and Diabetic Retinopathy (DR): World Drug Market 2013-2023
US$ 2,401.00
... you discover its potential Where are treatments for macular degeneration (AMD) and diabetic retinopathy (DR) heading? Visiongain's updated report gives you ... will reach $6.25bn in 2015, our report forecasts. Ageing populations, diabetes and improving healthcare will increase sales of retinal drugs. In our ...
November 2012
153 pages
Social and Mobile Pharma - the State of the Digital Landscape
US$ 445.00
... consumers themselves are able to express concerns online. The influence of social media on pharma marketing is such that even the largest and most ... looks at leading-edge activities such as data mining, investigates the future of mobile access, outlines legislative and regulatory efforts worldwide and offers ...
October 2012
94 pages
US OTC Pharmaceutical Market Guide
US$ 197.00
... about the U.S. OTC Pharmaceutical Market’s competitive landscape, market share and industry segmentation in this research report. The United States is a large ... expected to grow at a moderate pace in the coming years, the U.S. OTC pharmaceuticals market is also looking for a decelerated growth till the year ...
October 2012
62 pages
Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2012-2022
US$ 2,401.00
... . You discover individual revenue forecasts to 2022 for these geographical markets: US Japan Germany, France, UK, Italy and Spain (EU5 countries, as a group) ... . Our work shows and explains. Seven ways Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2012-2022 helps you To sum up, our ...
October 2012
145 pages
Pharma Leader Series: Top 20 Ophthalmic Drug Manufacturers 2012-2022
US$ 2,401.00
... ? Our study also covers 20 other companies following after the world leaders. You discover activities of organisations including the following: BioDiem CoMentis ... will develop and prosper, our analysis shows. Nine ways Pharma Leader Series: Top 20 Ophthalmic Drug Manufacturers 2012-2022 benefits you To ...
October 2012
166 pages
Global Pharmaceutical Market Report & Forecast: 2012-2017
US$ 1,400.00
The global pharmaceutical market is expected to grow at a CAGR of 5% during 2011-2017, exceeding sales worth US$ 1.1 Trillion by 2017. This market, however, is expected to undergo a number of transiti...
October 2012
Alzherimer's Drugs Market, 2012-2017
US$ 1,699.00
... five years, from 2012-2017, will see the launch of many new drugs. Scope of the Report The Alzheimer’s drug market (2011-2017) ... III clinical trials. Chapter 8 provides profiles of the key companies in this market. Each company profile includes information such as financial performance, geographical ...
October 2012
117 pages
Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2012-2022
US$ 2,401.00
... - you see prospects to 2022 for Sandoz Will Sandoz remain the market leader? See information on its activities in 2012, looking ahead. You find discussion ... leading generics specialists - will develop and prosper. Eight ways Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2012-2022 helps you To ...
October 2012
182 pages
Competitor Analysis: Pneumococcal and Streptococcal Vaccines
US$ 260.00
... , Company, Product Category, Indication, R&D Stage and additional comments with a hyperlink leading to the source of information. About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, ...
October 2012
21 pages
The US Specialty Pharmaceutical Market Report: 2012 Edition
US$ 800.00
... which fall within the bounds of specialty pharmaceuticals. There is no particular definition for specialty pharmaceutical but on the basis of some ... overview of the US specialty pharmaceutical market covering various disease segments and the specialty pharmacy market. The specialty pharma realm is intensely ...
September 2012
65 pages
Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments
US$ 3,995.00
... past year, and these are covered in this report Vaccines 2012: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing ... elderly populations. This report includes profiles of the key players in vaccines, including: AlphaVax, Inc. Bavarian Nordic A/S Baxter Healthcare Bharat Biotech ...
September 2012
249 pages
Data report-Production Situation of Vitamin B2
US$ 1,490.00
... This report provides you concise information about the vitamin B2 industry in China, discovering not only the latest dynamics of production situation and producers ... , but also price, import and export, and the application fields of the vitamin B2 products. Besides, ...
September 2012
13 pages
World Multiple Myeloma Drug Treatment Market 2012-2022
US$ 2,635.00
... will arise for companies treating cancers. Nine ways World Multiple Myeloma Drug Treatment Market 2012-2022 helps you In particular, then, ... following knowledge on the topic: Forecasted revenue to 2022 for the overall world market - find the industry's prospects Potential revenues of 10 products to 2022 ...
September 2012
136 pages
The World Market for Transdermal Drug Delivery
US$ 2,500.00
... and the ability to quickly discontinue treatment by removal of the system. This report, World Markets for Transdermal Drug Delivery is a comprehensive look at the ... , revenues have been reported that include pharmaceutical sales for products utilizing that technology. This market is divided into two segments ...
September 2012
100 pages
Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022
US$ 2,635.00
... top sales places. Also, most of those products will continue revenue growth. Seven ways Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022 helps you In particular, our report gives you the following knowledge on producers of biologics: Profiles of 20 leading ...
September 2012
187 pages
Competitor Analysis: Tuberculosis Vaccines and Therapeutics
US$ 516.00
... targeting Mycobacterium tuberculosis for prophylaxis and treatment of tuberculosis. In addition, the report lists corporate and public R&D pipelines of Tuberculosis Vaccines & Therapeutics. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action ...
September 2012
70 pages
Global Generic Drugs Industry 2012-2017: Trend, Profit, and Forecast Analysis, September 2012
US$ 1,980.00
... , a leading global management consulting and market research firm, has analyzed the global generic drugs industry and presents its findings in Global Generic Drugs Industry 2012-2017: Trend, Profit, and Forecast Analysis. The industry comprises firms primarily engaged in the development, manufacture, and marketing of generic drugs. The generic ...
September 2012
Pharma and Payers – Building Better Relationships
US$ 895.00
Changes in the healthcare landscape have put payers (public and private) under mounting pressure to reduce the cost of care, and given them much greater influence over market access to new medicines.I...
August 2012
67 pages
Pharmaceutical Contract Manufacturing: World Market Outlook 2012-2022
US$ 2,635.00
... . In our investigation you find revenue forecasting, growth rates and market shares. Also, you see qualitative analyses, including discussions of regulatory ... growth from this decade onwards. SEVEN WAYS PHARMACEUTICAL CONTRACT MANUFACTURING: WORLD MARKET OUTLOOK 2012-2022 BENEFITS YOU In particular, then, ...
August 2012
173 pages
